MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-kB activity

Neuro-Oncology

Volumn 15, Issue 4, 2013, Pages 413-422

  Xia, Hongping ^a   Yan, Yukui ^b   Hu, Minghua ^a   Wang, Yaxian ^b   Wang, Yongsheng ^c   Dai, Yi ^a   Chen, Jianming ^a   Di, Guangfu ^a   Chen, Xiaobing ^c,d   Jiang, Xiaochun ^a  

^a WANNAN MEDICAL COLLEGE   (China)

^b HUZHOU CENTRAL HOSPITAL   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; ECOP; Glioma; MiR 218; NF kB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CARCINOGENICITY; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; ENZYME ACTIVITY; FLOW CYTOMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL PROLIFERATION; FLOW CYTOMETRY; GLIOMA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84875716955     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos296     Document Type: Article

References (30)

1. Van Meir EG, Hadjipanayis CG, Norden AD, Shu H-K,Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166-193.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
3. Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol. 2010;67(3):279-283.
4. Park DM, Sathornsumetee S, Rich JN. Medical oncology: treatment and management of malignant gliomas. Nat Rev Clin Oncol. 2010;7(2):75-77.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233.
6. Long JM, Lahiri DK. Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp Neurol. 2012;235(2):402-418.
7. Park S, James CD. ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-[kappa]B transcriptional activity and associated apoptotic response in an I[kappa]B[alpha]-dependent manner. Oncogene. 2005;24(15):2495-2502.
8. Xu B, Hsu P-K, Karayiorgou M, Gogos JA. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis. 2012;46(2):291-301.
9. Pang J, Kwok W, Chen Z, Ng H-K. Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 2009;117(6):599-611.
10. Godlewski J, Nowicki MO, Bronisz A, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008;68(22):9125-9130.
11. Silber J, Lim D, Petritsch C, et al. MiR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6(1):14.
12. Rao SAM, Santosh V, Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol. 2010;23(10):1404-1417.
13. Song L, Huang Q, Chen K, et al. MiR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-[beta]. Biochem Biophys Res Commun. 2010;402(1):135-140.
14. Xia H, Qi Y, Ng SS, et al. MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun. 2009;380(2):205-210.
15. Jiang PD, Zhao YL, Deng XQ, et al. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomed Pharmacother. 2010;64(9):609-614.
16. Ning X, Sun S, Hong L, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res. 2007;5(12):1254-1262.
17. Galardi S, Mercatelli N, Giorda E, et al. MiR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem. 2007;282(32):23716-23724.
18. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37(suppl 1):D105-D110.
19. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70.
20. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
21. Jovanovic M, Hengartner MO. MiRNAs and apoptosis: RNAs to die for. Oncogene. 2006;25(46):6176-6187.
22. Cimmino A, Calin GA, Fabbri M, et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci US A. 2005;102(39):13944-13949.
23. Chan JA, KrichevskyAM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029-6033.
24. Baras A, Moskaluk C. Intracellular localization of GASP/ECOP/VOPP1. J Mol Histol. 2010;41(2):153-164.
25. Baras A, Yu Y, Filtz M, Kim B, Moskaluk C. Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene. 2009;28(32):2919-2924.
26. Eley GD, Reiter JL, Pandita A, et al. A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma. Neuro-oncology. 2002;4(2):86-94.
27. Laver T, Nozell S, Benveniste EN. The NF-kB signaling pathway in GBMs: implications for apoptotic and inflammatory responses and exploitation for therapy. CNS Cancer. 2009:1011-1036.
28. Prasad S, Ravindran J, Aggarwal BB. NF-kB and cancer: how intimate is this relationship? Mol Cell Biochem. 2010;336(1):25-37.
29. Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res. 2010;70(18):7027-7030.
30. Roth P, Wischhusen J, Happold C, et al. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem. 2011;118(3):449-457.